Yurista, Salva R.
Silljé, Herman H. W.
Rienstra, Michiel
de Boer, Rudolf A.
Westenbrink, B. Daan
Article History
Received: 22 October 2019
Accepted: 26 December 2019
First Online: 7 January 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable. All authors agree to publication, and there are no permissions needed.
: SRY, HHWS, MR and BDW do not report competing interests relative to this report. The UMCG, which employs Dr. De Boer has received research grants and/or fees from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Roche, Trevena, and ThermoFisher GmbH. Dr. de Boer received personal fees from MandalMed Inc, Novartis, and Servier.